U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness.
The Food and Drug Administration advisory applies to lubricating drops sold by six companies, including CVS Health, Target, Rite Aid and Cardinal Health. Consumers should stop using the products immediately and avoid purchasing any that remain on pharmacy and store shelves, the FDA said in a statement Friday.
The agency asked the companies to recall their products last week, because FDA inspectors found unsanitary conditions and bacteria at the facility producing the drops. The FDA did not disclose the location of the factory or when it was inspected.
No injuries related to the products had been reported at the time of the announcement, but the FDA encouraged doctors and patients to submit cases through the agency’s online reporting system.
Earlier this year, federal officials linked an outbreak of drug-resistant bacteria to eyedrops from two companies, EzriCare and Delsam Pharma. More than 80 people in the U.S. tested positive for eye infections from the rare bacterial strain, according to the most recent update from the Centers for Disease Control and Prevention.
After the products were recalled in February, health inspectors visited the manufacturing plant in India that made the eyedrops and uncovered problems with how they were made and tested, including inadequate sterility measures.
California regulators are preparing to vote on new rules for turning recycled wastewater into drinking water.
The Biden administration is moving to conserve old-growth forests on national forests and limit logging as climate change amplifies the threats they face from wildfires, insects and disease.
With high healthcare costs, bills can quickly add up. In some cases, it is possible to negotiate your medical bills. Barak Richman, law professor at George Washington University, joined Cheddar News to discuss the easiest way to talk to medical debt companies about what's owed.
Millions of people have selected insurance plans for 2024 but sometimes navigating them can be tricky time consuming and expensive. Paula Pant, host of 'Afford Anything' podcast, joined Cheddar News to break down what's needed to know about their insurance plans.
A new study is shedding light on the benefits of the fast-mimicking diet and heart health.
A study published in the journal E-Clinical Medicine suggests there may be a link between air pollution and an increased risk of dementia and strokes.
A new pill is now available to treat postpartum depression.
Prescribed burn associations are proving key to conservationists’ efforts to restore a longleaf pine range forming the backbone of forest ecology in the American Southeast.
A new study suggests higher blood sugar levels after eating could be a good thing.
The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.
